The Latest Breaking News from Pfizer

Emily O'Reilly, who heads the EU Ombudsman, says she has been stonewalled by the European Commission when asking for information in relation to the "Pfizergate" affair. At the core of this controversy is an exchange of text messages between the EU Commission chief and the CEO of Pfizer in the…

Novavax plans to update its Covid vaccine for new variants, and NVAX stock outperformed its vaccine stock rivals.

The President’s Emergency Program for AIDS Relief, or PEPFAR, has revolutionized the fight against global AIDS over the last 20 years. In that time, the U.S. program has brought antiretroviral treatment to nearly 19 million people living with HIV, the virus that causes AIDS; prevented mother-to-child transmission of HIV for…

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

People in the US have been sharing videos on social media showing them seemingly trembling and shaking

A Pfizer booster that specifically tackles two Omicron COVID-19 variants has been given provisional approval by the Therapeutic Goods Administration.

Queensland's fourth year of living with COVID-19 begins today – marking the anniversary of the first time the state's then Chief Health Officer Jeannette Young warned the public of a novel coronavirus emerging out of China.

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

The federal government is waiting on advice about whether Australians should have a fifth COVID-19 vaccine. So, how many people have had the current boosters and who is eligible for what?